<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Biotech Blog &#187; Guest content</title>
	<atom:link href="http://www.biotechblog.com/category/guest-content/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.biotechblog.com</link>
	<description>Commercial, legal, political, and scientific trends in biotechnology</description>
	<lastBuildDate>Sat, 11 Feb 2012 11:38:55 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>Guest Post: Biotechnology Patent Trolls</title>
		<link>http://www.biotechblog.com/2012/02/08/guest-post-biotechnology-patent-trolls/</link>
		<comments>http://www.biotechblog.com/2012/02/08/guest-post-biotechnology-patent-trolls/#comments</comments>
		<pubDate>Wed, 08 Feb 2012 06:00:51 +0000</pubDate>
		<dc:creator>fintan</dc:creator>
				<category><![CDATA[General Biotechnology]]></category>
		<category><![CDATA[Guest content]]></category>

		<guid isPermaLink="false">http://www.biotechblog.com/?p=6315</guid>
		<description><![CDATA[Copyright &#169; BiotechBlog, partner of DrugPatentWatch, and a product of thinkBiotech This is a guest post from the BiotechBlog Itntern,  Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin City University. Do you have a response to Fintan’s post? Respond in the comments section below. According to a BDO industry report, [...]]]></description>
		<wfw:commentRss>http://www.biotechblog.com/2012/02/08/guest-post-biotechnology-patent-trolls/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>IPO on the Cheap?</title>
		<link>http://www.biotechblog.com/2011/04/18/ipo-on-the-cheap/</link>
		<comments>http://www.biotechblog.com/2011/04/18/ipo-on-the-cheap/#comments</comments>
		<pubDate>Mon, 18 Apr 2011 12:53:02 +0000</pubDate>
		<dc:creator>BiotechBlog</dc:creator>
				<category><![CDATA[General Biotechnology]]></category>
		<category><![CDATA[Guest content]]></category>
		<category><![CDATA[ipo]]></category>
		<category><![CDATA[otc]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[sec]]></category>

		<guid isPermaLink="false">http://www.biotechblog.com/?p=3297</guid>
		<description><![CDATA[Copyright &#169; BiotechBlog, partner of DrugPatentWatch, and a product of thinkBiotech This is a guest post by Jurgita Ashley You are a small company ready to take a leap into the public market, whether it is for growth, liquidity or to attract greater investor interest. But, oh man, those dollar figures for IPOs would make [...]]]></description>
		<wfw:commentRss>http://www.biotechblog.com/2011/04/18/ipo-on-the-cheap/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>The Best Online Tech Schools Out There</title>
		<link>http://www.biotechblog.com/2010/12/15/the-best-online-tech-schools-out-there/</link>
		<comments>http://www.biotechblog.com/2010/12/15/the-best-online-tech-schools-out-there/#comments</comments>
		<pubDate>Wed, 15 Dec 2010 20:53:56 +0000</pubDate>
		<dc:creator>BiotechBlog</dc:creator>
				<category><![CDATA[General Biotechnology]]></category>
		<category><![CDATA[Guest content]]></category>
		<category><![CDATA[education]]></category>

		<guid isPermaLink="false">http://www.biotechblog.com/?p=2619</guid>
		<description><![CDATA[Copyright &#169; BiotechBlog, partner of DrugPatentWatch, and a product of thinkBiotech This entry is a guest blog series from the Paul Bradford With new technological advances being made every day, biotechnology is a fast growing field of science. Biotechnologists in both the private and publicly funded sector are pioneering research in combining new technology with [...]]]></description>
		<wfw:commentRss>http://www.biotechblog.com/2010/12/15/the-best-online-tech-schools-out-there/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Technology Continues to Fight Aids</title>
		<link>http://www.biotechblog.com/2010/12/06/technology-continues-to-fight-aids/</link>
		<comments>http://www.biotechblog.com/2010/12/06/technology-continues-to-fight-aids/#comments</comments>
		<pubDate>Mon, 06 Dec 2010 22:14:18 +0000</pubDate>
		<dc:creator>BiotechBlog</dc:creator>
				<category><![CDATA[General Biotechnology]]></category>
		<category><![CDATA[Guest content]]></category>

		<guid isPermaLink="false">http://www.biotechblog.com/?p=2547</guid>
		<description><![CDATA[Copyright &#169; BiotechBlog, partner of DrugPatentWatch, and a product of thinkBiotech This is a guest post from BiotechBlog reader Jack Lundee Technology Continues to Fight Aids In 2008, Sub-Saharan Africa was populated with over 22 million HIV+ inhabitants, and currently there are over 5 million Southern Africans infected with the virus. Worldwide, there are upwards [...]]]></description>
		<wfw:commentRss>http://www.biotechblog.com/2010/12/06/technology-continues-to-fight-aids/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biosimilar drugs to gain greater priority as decade progresses</title>
		<link>http://www.biotechblog.com/2010/06/21/biosimilar-drugs-to-gain-greater-priority-as-decade-progresses/</link>
		<comments>http://www.biotechblog.com/2010/06/21/biosimilar-drugs-to-gain-greater-priority-as-decade-progresses/#comments</comments>
		<pubDate>Mon, 21 Jun 2010 15:39:04 +0000</pubDate>
		<dc:creator>BiotechBlog</dc:creator>
				<category><![CDATA[General Biotechnology]]></category>
		<category><![CDATA[Guest content]]></category>
		<category><![CDATA[biogeneric]]></category>
		<category><![CDATA[biologic]]></category>
		<category><![CDATA[biosimilar]]></category>
		<category><![CDATA[competition]]></category>

		<guid isPermaLink="false">http://www.biotechblog.com/?p=1469</guid>
		<description><![CDATA[Copyright &#169; BiotechBlog, partner of DrugPatentWatch, and a product of thinkBiotech This is a guest post from Keith Bradbury, Executive Director of Drug Information at Medco Health Solutions, Inc. Biosimilar drugs to gain greater priority as decade progresses The Patient Protection and Affordable Care Act will heighten the degree of competition in the field of [...]]]></description>
		<wfw:commentRss>http://www.biotechblog.com/2010/06/21/biosimilar-drugs-to-gain-greater-priority-as-decade-progresses/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
	</channel>
</rss>

